Successful gene delivery to preclinical medulloblastoma models using mammalian viruses such as AAV has been reported to induce regression of tumor growth using Tis21 as a medulloblastoma suppressor gene; however, the direct delivery to the tumor tissue by intratumoral injections was inevitable.1 The gene discussed is BTG2; the disease is neoplasm.